ADVISORY BOARD

• LG Almeda | Mostafa Analoui | David Arthur | Craig Bandes | Lynn Bergeson | Keith Blakely | Rick Canady | Anil Diwan | Ron Durando | Charlie Gause | Peter Hébert | Jim Hussey | Douglas Jamison | Brian Johnston | Jess Jankowski | Phil Lippel | Scott Livingston | Kimberly McGrath | Ed Moran | Joe Piche | Bradley Pietras | Leonard Poveromo | Leon Radomsky | P. Markondeya Raj | David Reisner | Scott Rickert | Jeff Rosedale | Skip Rung | Penelope T. Salmon | Paul Stimers | Todd Vare | Steven R. Waite | David Wallace | Chad Wieland |

• LG Almeda, Shareholder, Chair of Nanotechnology Practice Team
  Lawrence G. Almeda is chair of the Nanotechnology Practice Group at Brinks Hofer Gilson & Lione. Mr. Almeda focuses his practice on patent opinions and prosecution in the medical, chemical, nanotechnology and mechanical arts. His practice has an emphasis on medical devices, nanomaterials, micro and nanodevices, petroleum and chemical processes, polymers, fuel cells, hybrid engines and polycarbonate glazing systems. He also has significant experience in counseling clients on patent infringement and validity evaluations.

• Mostafa Analoui, Head of Healthcare and Life Science, The Livingston Group  
  Mostafa Analoui, Ph.D., is Head of Healthcare and Life Science at The Livingston Group (New York, NY) and Senior Vice President of Business Development at Charlesson Pharmaceuticals. Previously he was the Senior Director at Pfizer Global Research and Development in Connecticut. He is also adjunct Professor of Oral Pathology, Medicine and Radiology at Indiana University. Dr. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies. Prior to joining Pfizer, Dr. Analoui was the Director of Oral and Maxillofacial Imaging Research at Indiana University, and Associate professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc. In addition to industry leadership in biomedical and technology fields, he lectures and consults nationally and internationally. He has also served on various scientific, regulatory, and business advisory committees and boards. Dr. Analoui has authored over 130 publications, including journal articles, book chapters, and technical reports.  He currently serves as board member of VirtualScopics Inc, BPT Pharma, NanoBusiness Alliance, and Calando Pharmaceuticals.

• David Arthur, Chief Executive Officer, SouthWest NanoTechnologies, Inc.
  David J. Arthur has 30 years experience commercializing products utilizing advanced materials, including work at Rogers Corporation, A.T. Cross, TPI Composites, Helix Technologies, and Eikos. He holds a bachelor of science degree in chemical engineering from Tufts University, master of science degree in chemical engineering from the University of Connecticut and a master of business administration degree from Northeastern University. In 2005, Arthur co-founded Chasm Technologies, a consulting firm that helps its clients commercialize new products through smart application of materials science and process technology. For the past four years, he has been CEO of SouthWest NanoTechnologies (SWeNT), a leading producer of specialty carbon nanotube materials for coatings and composites applications.

• Craig Bandes, CEO, Pixelligent Technologies
  Craig Bandes has been serving as the CEO of Pixelligent Technologies since 2009. Mr. Bandes has nearly 20 years of experience as a CEO, entrepreneur, and angel investor building companies in the technology, defense and professional services industries. Since his joining as CEO, Pixelligent has successfully emerged from a Ch 11 reorganization, raised $3M in equity, has been awarded nearly $9M in new U.S. government grants, has entered into a joint venture with a leading polymer company, and has accelerated the commercialization of its technology in the commercial and military markets. Prior to Pixelligent, Mr. Bandes was the President & CEO of Global Secure Corp, a high tech company focused on providing homeland security solutions. He grew Global Secure from a start-up to 175 people, raised $25M, and acquired four companies. Prior to Global Secure he was the Co-Founder of Focus Technology Consulting which was ranked #14 on the 2009 Washington Technology Fast 50 list. Mr. Bandes has negotiated over $300 million in financial transactions and completed acquisitions and strategic partnerships in the United States, Asia and Europe. Mr. Bandes sits on the Board of Directors of Pixelligent, Delta Solutions & Technologies, and Focus Technology. Mr. Bandes has been a guest speaker on the topics of entrepreneurship, venture capital, and strategic partnerships at numerous college and university MBA programs. He has also presented at several investment banking conferences and was a guest speaker at the House of Lords in the UK. Mr. Bandes received degrees in Finance and Entrepreneurship from Babson College.

• Lynn Bergeson, Managing Director, Bergeson & Campbell, P.C.
  Lynn L. Bergeson is Managing Director of Bergeson & Campbell, P.C. (B&C), a Washington, D.C. law firm concentrating on conventional and engineered nanoscale chemical, pesticide, and other specialty chemical product regulation and approval matters, domestic and foreign chemical classification, chemical product litigation, and associated business issues. Ms. Bergeson is also President of The Acta Group, L.L.C. and The Acta Group EU, Ltd, B&C’s consulting affiliates, with offices in Washington, D.C. and Manchester, U.K., respectively. 
  Ms. Bergeson counsels clients on health, safety, science policy, and related legal and regulatory aspects of traditional domestic chemical regulatory programs under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) and the Toxic Substances Control Act (TSCA), as well as on issues pertinent to nanotechnology and other emerging transformative technologies.  Ms. Bergeson serves on the President’s Council of Advisors on Science and Technology (PCAST) Nanotechnology Technical Advisory Group (PCAST nTAG), and served on the U.S. Environmental Protection Agency’s (EPA) Steering Committee for the Pollution Prevention through Nanotechnology Conference. Ms. Bergeson served in 2004 and 2005 on the American National Standards Institute (ANSI) Nanotechnology Standards Panel (NSP) Steering Committee and is now a member of the ISO Technical Committee 229 on Nanotechnologies. Ms. Bergeson also serves on the Board of Directors of Earth Day Network and is a member of its Executive Committee. She serves on the Board of the Converging Technologies Bar Association (CTBA) and is Chair of the CTBA Environmental, Health, and Safety Committee. Ms. Bergeson was Chair of the American Bar Association (ABA) Section of Environment, Energy, and Resources (SEER) (2005-2006), is the past Chair of the SEER Pesticides, Chemical Regulation, and Right-to-Know Committee (PCRRTKC) (2006-2008), and is now Vice Chair of the PCRRTKC, and serves in other ABA leadership positions. Ms. Bergeson is also a member of the ALI-ABA Environmental Law Advisory Panel.

• Keith Blakely, CEO of NanoMech, LLC
  Keith Blakely is the CEO of NanoMech, LLC, an award-winning technology commercialization company based in Springdale, Arkansas focused on the development and manufacturing of patented and proprietary application-specific nanomaterials, nanoparticle-based coatings and coating deposition systems, and nano-enabled products. Keith is a serial entrepreneur, having started his first company, Advanced Refractory Technologies, Inc. (ART), in Buffalo, NY in 1981 at the age of 24 after spending four years at the Carborundum Company in Niagara Falls, NY. For the next twenty years, he served as ART’s Chairman, President & CEO, overseeing its growth from a 2 person operation to over 300 people with two international joint ventures and three domestic facilities. During his tenure, he established relationships with General Motors, Bekaert, Mitsubishi, Westinghouse, McDermott International, United Defense, and many others. The company was recognized as a worldwide leader in advanced materials when it was acquired by a subsidiary of Tyco International in June, 2001.
  Following the sale of ART, Mr. Blakely established a technology management consulting organization – The InVentures Group – which provides technology assessments, business planning, and technology commercialization to organizations on a global basis. In that capacity, Blakely served as the COO of a NASDAQ listed fuel cell company headquartered in NYC and the CEO of a privately-held nanomaterials company based in St. Louis, MO. He also founded and serves as Chairman of First Wave Technologies, Inc., an organization dedicated to the commercialization of innovative products and technologies developed in upstate NY. In 2002, Blakely started NanoDynamics, Inc., a leader in the commercialization of nanomaterials and nanotechnology-enabled components and systems. He served as its CEO until 2009, overseeing the development and commercial launch of disruptive new products for the energy, environmental, and infrastructure markets.
  Mr. Blakely, who was elected a Fellow of the American Ceramic Society in 2001, has significant board-level experience and has served on the boards of several public and private organizations, including the Buffalo-Niagara International Trade Council, the Western New York Technology Development Corporation, and the Buffalo Economic Renaissance Corporation. He is a two time winner of Research and Development Magazines “IR-100” award for the 100 most technologically significant new products, holds several US patents, was profiled in Figaro magazine, has appeared on CNBC’s Squawkbox business program, and is the author of numerous technical and business articles. In 2007, he was named Business Leader of the Year by Small Times Magazine.

• Rick Canady
  Richard A. Canady is a leading expert in regulatory risk assessment and nanotechnology regulatory policy having led multidisciplinary teams of policy and technical experts in the resolution of a wide range of cutting edge health risk management issues over a 20 year career that includes genomics, nanotechnology, biotechnology, obesity, contaminants in foods and medical products (including mercury, dioxins, perchlorate, and acrylamide), and medical product development.
  Mr. Canady has a breadth of experience and insight in government regulatory policy for health risk assessment from the executive level, integrating across product review centers for the FDA Office of the Commissioner and across Federal Agencies for the Executive Office of the President. His experience includes substantial international work, leading policy and technical analysis teams within the Organization for Economic Cooperation and Development, the World Health Organization, and the Food and Agriculture Organization as well as in direct bilateral interactions with major U.S. trading partners on chemical risk management issues facing FDA.

• Anil Diwan, President and Chairmain, NanoViricides, Inc.
  Anil Diwan is the president of Nanovicides, Inc. a company developing novel antiviral technologies.  Located in West Haven, CT, this firm has developed a platform technology which has been shown to have excellent efficacy in laboratory studies on the viruses that lead to: HIV, herpes simplex, various forms of influenza, as well as several viral ophthalmic infections. Nanoviricides technology (licensed from TheraCour®, a privately held company founded by Dr. Diwan.) involves novel polymeric-micelles which have been under development since 1991.  The technology has one issued patent, three filed international patent applications, and several additional patent applications in various stages. NanoViricides, Inc. was founded by Dr. Diwan, Dr. Seymour and others to commercialize these unique nanomedicine antiviral technologies.
  Dr. Diwan is a prolific inventor and a serial entrepreneur. Prior to founding NanoViricides, Inc., he has founded TheraCour Pharma, Inc., a privately held company working in nanomedicines.  Additionally he founded AllExcel, Inc., a company with diverse portfolio including nanomedicines, small chemicals, device technologies, and informatics. He has won several NIH SBIR grant awards.
  Anil holds a Ph.D. from Rice University, TX, and a Bachelors in Technology from the Indian Institute of Technology, Bombay (IIT-B), India.  He has over 18 years of bio-pharmaceutical R&D experience as well as 12 years of experience as an entrepreneur.

• Ron Durando, Microphase Corporation, Chief Operating Officer
  Ron Durando is a long time, successful entrepreneur. He has a background in both engineering and corporate finance. Ron has been Chief Operating Officer of Microphase since 1994. When he joined Microphase, he worked with founder Ned Ergul to revive the corporation and adjust both its mission and operating style to accommodate changes in the market. He was instrumental in turning around the company and has doubled its revenues during his tour as Chief Operating Officer.
  Ron started and successfully ran an RF Contract Manufacturing based in China in from August 1996 until December 2008. The company grew from 6 employees operating in 6500 sq feet to over 1000 employees at it’s peek in a 150,000 square foot facility.
  In October 1996 he founded mPhase Technologies, Inc. He has been its President and Chief Executive Officer since the company's inception. Under Ron’s leadership mPhase produced and sold a very successful line of DSL components and he has now completed the transition of mPhase into a battery technology company that is now developing an innovative battery technology based upon breakthroughs in Microfludics and Nanotechnology.

• Charlie Gause, Vice President Corporate Business Development & Founder, nanoWorks Division
  In late 2004, Luna Innovations successfully launched a public-private partnership to establish a one-of-a-kind nanomaterials development and manufacturing facility in Danville, Virginia called Luna nanoWorks. Charles Gause directed this project which transformed a 24,000-square-foot historic tobacco warehouse into a premiere nanomaterials facility, by establishing division operations, business development, and manufacturing processes.  With an extensive manufacturing and engineering science background, Gause is currently identifying and developing market opportunities based upon Luna’s nanotechnologies including therapeutic and diagnostic pharmaceutical products, alternative energy solutions with organic solar cells and defense applications.
  Gause is active in nanotechnology policy initiatives such as the NanoHealth Enterprise, Northern Virginia’s Technology Council’s Nanotechnology Committee and is a founding member of the Accelerating Innovation Foundation.  Likewise, he is a member of the State of Virginia’s Joint Commission on Technology and Science Nanotechnology Advisory Committee (JCOTS) and is the President of the Southern Piedmont Technology Council (SPTC).  He serves on Danville Community College’s Workforce Advisory Board and the Chamber of Commerce’s Educational Advisory Board for Southern Virginia.

• Peter Hébert, Co-Founder and Managing Partner of Lux Capital
  Peter is a Co-Founder and Managing Partner of Lux Capital, focusing on investments in advanced materials, energy technology and semiconductors. Peter began his career at Lehman Brothers, where he worked in the firm's top-ranked Equity Research group. In 2000, he co-founded Lux Capital. In 2003, Peter led the spin-off of Lux Research. As founding CEO, he helped build Lux Research into the leading emerging technology research firm. Peter launched the publicly-listed Lux Nanotech Index [AMEX: LUXNI] and the $150 million PowerShares Lux Nanotech Portfolio [AMEX: PXN].
  Peter manages Lux Capital's investments in Accelergy, Angstrom Publishing, Everspin Technologies, Lux Research, Luxtera and several stealth energy ventures. He was a Chancellor's Scholar and graduated cum laude from Syracuse University's Newhouse School. Peter was the Founding President of Syracuse's first venture organization, Future Business Leaders and Entrepreneurs. He has been an invited speaker, guest lecturer and panelist at CNBC, Bloomberg, Yale, Columbia, Cornell, MIT, and the National Science Foundation. Peter also co-founded Young Wall Street, a charitable organization supporting youth-related causes in New York City.

• Jim Hussey, Chief Executive Officer, NanoInk
  James M. Hussey joined NanoInk, as Chief Executive Officer and member of the Board of Directors, in January 2008. Mr. Hussey brings 25 years of experience in the pharmaceutical and biotechnology industry as executive, founder, investor and consultant to senior management and boards of directors. Prior to joining NanoInk, Mr. Hussey was with Ovation Pharmaceuticals, where he was a member of the senior operating committee, serving as Head of Alliances and Vice President of Corporate Development. He was President and CEO of NeoPharm, Inc., as well as a member of the Board of Directors and an investor/shareholder. In 1994, he founded Physicians Quality Care, a health care services IPA Management Company, which was sold to a public company in 1998. Prior to founding Physicians Quality Care, he was with Bristol Myers Squibb in Princeton, New Jersey, serving as General Manager as well as other positions in marketing, new business development and sales. Mr. Hussey holds a B.S. in Pharmacy from Butler University, Indianapolis, Indiana, and an M.B.A. from University of Illinois at Chicago.

• Douglas Jamison, Chairman and Chief Executive Officer, Harris & Harris Group
  Mr. Jamison is Chairman and Chief Executive Officer and a Managing Director of Harris & Harris Group, Inc., a publicly traded venture capital company listed on the Nasdaq Global Market (NASDAQ: TINY).  Harris & Harris Group focuses solely in making initial investments in “tiny” technologies, which it defines as nanotechnology and microsystems. He has previously held the positions of President, Chief Operating Officer and Chief Financial Officer of Harris & Harris Group, Inc.  He is also currently Chairman and Chief Executive Officer of Harris & Harris Enterprises, Inc., a wholly owned subsidiary of Harris & Harris Group.  He is a member of the Board of Directors of Ancora Pharmaceuticals, Inc., and a Board observer in Mersana Therapeutics, Inc., Solazyme, Inc., Nextreme Thermal Solutions, Inc., and Metabolon, Inc., privately held nanotechnology-enabled portfolio companies of Harris & Harris Group.  He is Co-Editor-in-Chief of “Nanotechnology Law & Business.”  He is Co-Chair of the Advisory Board, Converging Technology Bar Association, a member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board, and a member of the Advisory Board, Massachusetts Technology Collaborative Nanotechnology Venture Forum.  Prior to joining Harris & Harris Group, he was a Senior Technology Manager at the University of Utah Technology Transfer Office, where he managed intellectual property in physics, chemistry and the engineering sciences.  He is a graduate of Dartmouth College (B.A., 1992) and the University of Utah (M.S., 1999).

• Jess Jankowski, President & Chief Executive Officer, Nanophase Technologies Corporation
  Nanophase Technologies Corporation, a charter member of the NanoBusiness Alliance, is an FDA-regulated developer and manufacturer of advanced material solutions as well as the first, and one of the few, publicly traded pure-play nanomaterials companies.  Mr. Jankowski joined the Company in 1995 as Controller, helping to take Nanophase public in 1997.  He is the Company’s President and Chief Executive Officer, and a board director.  Mr. Jankowski has previously held the positions of Chief Financial Officer and Vice President of Finance.  Prior to Nanophase, he served as Controller for two building contractors in the Chicago area for four years, during which time he had significant business development and governmental relations responsibilities.  Prior to that he worked for Kemper Financial Services for four years in various roles.  Mr. Jankowski holds a B.S. in accountancy from Northern Illinois University and an M.B.A. from Loyola University of Chicago. In 2009, Mr. Jankowski was appointed to the board of directors of the Northern Illinois Technology Foundation, an economic development and technology transfer entity that is part of Northern Illinois University. He was also elected to the TechAmerica Midwest Board in 2008.  He was also appointed to the Romeoville Economic Development Commission, an organization focused on fostering local new business growth, where he has served since 2004. He has also served on the advisory board of NITECH, an Illinois Technology Enterprise Center focusing on the commercialization of advanced manufacturing technologies from 2003 to 2008.  He has served as a Board Trustee for the Joliet Montessori School, a mission-driven alternative school established in 1969 and located southwest of Chicago, since 2008.  Mr. Jankowski remains active in supporting Nanophase, and the Illinois nano- and high-tech communities in the State of Illinois and in Washington DC. 
  As a responsible corporate citizen, Nanophase remains committed to best practices in corporate governance, having several former “Fortune 500” CEOs on its majority independent board of directors, and is proudly SOX-404 compliant.  Additionally, Nanophase’s facilities and processes were recertified in 2009 to ISO9001:2000, the internationally recognized standard of manufacturing and quality excellence, and ISO14001:2004, the international environmental management standard.  Nanophase operates all manufacturing facilities in compliance with State and Federal hazardous waste (RCCA), air emissions, and wastewater permits, while meeting or exceeding applicable OSHA, TSCA, and hazardous materials requirements.  In 2009, Nanophase employees reached a new safety record achieving over 1,000,000 continuous working hours without a lost time accident.

• Brian Johnston, Director, Kodak External Alliances Eastman Kodak Company
  Dr. Brian Johnston is employed at Eastman Kodak Company where he serves as Director, Kodak External Alliances. In this role, Brian works at the interface of a large corporation with small, early stage companies or university faculty to identify emerging technologies of future interest to Kodak. Brian engages Kodak scientists and business personnel with start-up entrepreneurs to bring technical and market perspectives in developing technology and business alliances with small companies. Brian facilitates the negotiations that often times lead to longer-term relationships. Brian brings to this role over 20 years experience in technology development and product commercialization, and has held a number of roles in basic research, manufacturing, product marketing and research laboratory management. Brian holds a Ph.D in organic chemistry from the University of Southampton, U.K. and an M.B.A. from the Simon School at the University of Rochester. He maintains an interest in a broad range of technologies, but has a focus on the media, materials and devices of use in printing applications, and in display related technologies.

• Phil Lippel Ph.D., Consultant on Nanoscience and Emerging Technologies
  Philip Lippel is an expert consultant on nanoscience and emerging technologies. He has worked on a variety of technical, policy, and science communication issues at the national and international level in fields including nanotechnology, science education and workforce, informatics, telecommunications, and commercialization of emerging technologies. Dr. Lippel has provided top level scientific support to the leadership of the U.S. National Nanotechnology Initiative; helped to keep Congress, the public, and other interested parties up to date on federally funded nanotechnology research and development; and liaised with companies, NGOs, and state agencies interested in nanotechnology commercialization. He was appointed as a U.S. delegate to the Working Party on Nanotechnology at the Organisation for Economic Co-operation and Development, and as a U.S. expert to the ISO/IEC Joint Technical Committee on Information and Communication Technologies. He served government as a senior policy analyst at the National Nanotechnology Coordination Office and as an AAAS Science and Technology Policy Fellow at the National Science Foundation; industry as a Member of Technical Staff at Agilent Technologies and as founder of L Cubed Consulting; and academia as a faculty member in the Physics Department of the University of Texas at Arlington. Dr. Lippel feels privileged to have been an early participant in the emergence of nanotechnology as a discipline, beginning with his use of scanning tunneling microscopes for materials research at the IBM Almaden Research Center and at UT Arlington, and as a tool for introducing college students to nanoscale science at L Cubed. He received an A.B. in Physics and in Theatre from Williams College, and the M.S. and Ph.D. degrees in Physics from Brandeis University.

• Scott Livingston, Chief Executive Officer, Livingston Securities LLC
  Scott Livingston is the Chief Executive Officer of the Livingston Group of Companies LLC and of Livingston Securities LLC, a full service investment bank/advisory and broker/dealer with a reputation as one of the leading experts on Wall Street and across America in the emerging field of nanotechnology. Nanotechnology has the potential to have a significant impact on a broad range of industries, including health/life science, energy/power, cleantech/greentech, industrial/defense, infrastructure/construction, electronics/semiconductors, consumer/leisure, and others. Mr. Livingston has been called “sharp and highly connected” by the Forbes Wolfe Nanotechnology Report (July 1, 2005) and has been a keynote speaker on advanced technology investment trends at MIT, the Harvard Club, the National Renewable Energy Lab (NREL), the Nanobusiness Alliance, the Cleveland Clinic, Brookhaven National Labs, the International Business Forum, Albany Nanotech, the Delaware Technology Park, Hillary Clinton’s Jobs for New York, WXXA Fox 23, Cold Spring Harbor’s Dolan DNA Learning Center and at conferences for economic development and job creation through investment in advanced technologies in over a dozen states across America.

• Kimberly McGrath, Director Fuel Cell Research, QuantumSphere
  Dr. McGrath has over ten years experience in renewable energy technologies, with emphasis on the design of catalytic materials for fuel cells, batteries, electrolyzers, and other electrochemical systems. Prior to joining QuantumSphere, Dr. McGrath worked with the University of Southern California and NASA’s Jet Propulsion Laboratory to develop and characterize robust new membranes for portable direct methanol fuel cells. In addition, she worked to develop new catalyst systems to improve the air-breathing fuel cell electrode, and in 2004 was invited by the Journal of Industrial & Engineering Chemistry to write an extensive treatise on Direct Methanol Fuel Cells with renowned fluorine chemist G.K. Surya Prakash and Nobel Laureate George A. Olah.
  Over the past few years, Dr. McGrath’s research at QSI has focused on improving the capacity of Li-ion batteries and the power density of portable fuel cells using non-noble metal high surface area catalysts, and studying emerging markets for many clean technologies.  Dr. McGrath received her B.S. in Chemistry from the University of California, Santa Cruz, a Ph.D. in Chemistry from University of Southern California, and is currently completing an Executive MBA program at University of California, Irvine. She is an active member of the Electrochemical Society, Fuels Division of the American Chemical Society, and is also engaged in R&D strategy related to valuation, introduction and adoption of emerging technologies.

• Ed Moran, Edward K. "Ed" Moran is a Global Deloitte
    Technology,  Media and  Telecommunications ( TMT) subject matter specialist for Technology, and he advises TMT companies in the areas of strategic planning, product innovation, competitive positioning and digital Convergence. Ed is the Technology Sector leader in Tri-State, and leads the Convergence team that develops Deloitte points of view on digital Convergence. 
  Ed works closely with Deloitte Research in developing publications and podcasts for the Technology, Media and Telecommunications sectors. He leads Deloitte’s   State of the Media Democracy Survey,  which provides up-to-date research on different demographics’ use and consumption of technology, media, social networking, advertising, content creation tools and interactive gaming.
  Ed has served for a number of years as a member of the World Economic Forum’s Technology Pioneer Selection Advisory Committee, has conducted workshops at the annual meeting in Davos, and was a member of the National Academies’ National Nanotech Initiative (NNI) Review Committee, which was chartered by Congress to evaluate the National Nanotechnology Initiative program. Ed writes, speaks and lectures both in the United States and internationally on the topics of digital Convergence, Community, Gen X/Y marketing principles, changing TMT business models, technology commercialization, technology trends, product innovation, business strategy, intellectual property and piracy, nanotechnology, technology transfer and the financing of technology companies. Ed is frequently quoted in the media, and has appeared in such mainstream and trade publications, television and radio shows as Advertising Age, B2B, BusinessWeek, Chemical and Engineering News, CNBC’s “Closing Bell,” CNNfn, Computer Power User, Entrepreneur, Forbes.com, Informationweek, Nanotech Planet, NBC’s Nightly News, the New York Law Journal, The New York Times, PharmaVoice, PRNews, SmallTimes and Wired.
  Prior to joining Deloitte Services, Ed was managing partner of a Manhattan law firm, where he served a number of technology and entertainment clients. Ed also was a managing director of a Manhattan investment and advisory company specializing in technology and media investments. Ed holds a law degree from New York Law School (where he was editor-in-chief of the Journal of International and Comparative Law), and earned a master in business administration degree in information systems and in management from New York University (where he was elected to Beta Gamma Sigma, and where he has taught corporate finance as an adjunct faculty member).

• Joe Piche, Founder, Eikos
  Joe has had an outstanding career in technology development, with more than 20 years experience developing high performance materials at Arthur D. Little, Foster Miller, and Aspen Systems.
  Capitalizing on his strong entrepreneurial drive, Joe founded Eikos in 1996 to leverage his broad experience in the advanced materials industry. Eikos develops unique carbon nanotube formulations and coating methods of these formulations into highly differentiated products for the commercial displays market and for a wide range of military applications.
  Joe recently received the prestigious Richard T. Whitcomb Aerospace Technology Transfer award from NASA. He has a BS in Chemistry from WPI.

• Bradley Pietras, Director, Technology Programs, Lockheed Martin
  Brad began his career at GE Astro Space in East Windsor, New Jersey. He left GE in 1990 to become a graduate fellow in Computational Neuroscience and PhD candidate in Neuroscience at the Institute for Sensory Research at Syracuse University. He returned to GE, now Lockheed Martin in 1996, joining the Advanced Programs group. After several years of managing missile defense research and development projects, he took the position as MS2 Radar Systems’ Missile Defense Business Development Manager in 2002. Brad held increasing levels of responsibility in domestic and international business development including strategic planning and congressional relations. In 2006, Brad became Director of Advanced Technology for MS2, responsible for research and development programs across the eight lines of business. Brad took his current position in Corporate Engineering and Technology in 2007 where he is the Director of the Lockheed Martin Corporate Nanotechnology Strategic Technology Thread. Brad holds a Bachelor’s of Science degree in Physics from the Rochester Institute of Technology and a Master’s of Science degree in Neuroscience from the College of Engineering at Syracuse University.

• Leonard Poveromo, Advanced Concepts & Integrated Solutions, Eastern Region Director, Technology Development, Northrop Grumman
  Leonard Poveromo is currently the Director of Technology Development for Northrop Grumman’s Integrated Systems Eastern Region.  Mr. Poveromo has held leadership positions in the Advanced Composite community throughout his 38-year career.  His technical contributions and involvement with professional societies have been significant to the Advanced Composites industry whose evolution his career has paralleled.  He currently is a fellow of SAMPE, a member of the Editorial Review Board of the SAMPE Quarterly Magazine, He is a member of the Advanced Energy Research and Technology Center Executive Board Member – SUNY Stony Brook, Air Force Office of Scientific Research Review Panel, Chemical and Molecular Engineering External Advisory Board – Polytechnic University, SUNY Stony Brook, Center of Excellence in Wireless and Information Technology (CEWIT) – SUNY Stony Brook – Executive Board, Industrial Advisory Board and South Carolina Research Authority’s Technical Advisory Board and Executive Steering Committee.  He has authored over 30 technical papers, holds several patents, was awarded SPI’s “Centerpoise Award”, and was past Program and General Chairman of SAMPE’s National Technical Conference and the Carbon Fiber Conferences.    Mr. Poveromo has a B.S. in Chemical Engineering from Lehigh University and an MBA from Hofstra University. 

• Leon Radomsky, Partner, Foley & Lardner LLP
  Leon Radomsky is a partner and chair of the Nanotechnology Industry Team of Foley & Lardner LLP. He is a member of the firm’s Chemical & Pharmaceutical and Electronics Practices and the Emerging Technologies and Energy Industry Teams. Mr. Radomsky focuses on strategic client counseling, IP due diligence and agreements, opinions and all phases of U.S. and international patent portfolio development, including patent application drafting, prosecution, appeals, reissues and reexaminations in the areas of nanotechnology, semiconductor devices and processing, materials science, solar cells and fuel cells.
  Prior to joining Foley, Mr. Radomsky worked as a patent examiner in the U.S. Patent and Trademark Office, where he examined patent applications in semiconductor device processing and developed a broad knowledge of semiconductor device and liquid crystal display fabrication technologies. Prior to that, he was a doctoral research assistant and teaching assistant at Columbia University, where he gained expertise in semiconductor physics and testing, metallurgy and electronic materials processing.
  Mr. Radomsky was recognized in the Legal 500 US 2009 Edition and in the Legal 500 US: Volume II: Intellectual Property, Media, Technology, and Telecom 2007 Guide as a top attorney for patent prosecution. He has also been named one of the Top Ten Intellectual Property Lawyers Influencing Nanotechnology by Nanotechnology Law & Business.

• P. Markondeya Raj, Associate Director at the 3D Systems Packaging Research Center (PRC), Georgia Tech
  Dr. P. Markondeya Raj is the Associate Director at the 3D Systems Packaging Research Center (PRC), Georgia Tech. At PRC, he provides leadership in the area of system component integration focusing on nanoscale components for power supply, high-speed digital packaging, RF/wireless and fine pitch interconnections. He managed and led several large government and industry funded research programs in these areas with a team of faculty, students and engineers. His research experience includes Next Generation Embedded Component Technologies and Multi-Mega Function Module Technologies for Electronic and Bio-electronic Systems. He has 10+ years experience in nanomaterials and processes for advanced packaging technologies including SOP, SiP, high-density substrates, thin film wiring, and embedded actives/passives. Dr. Raj is a member of the Nanopackaging Committee of IEEE CPMT chapter. He coauthored 3 books and 120 publications and has 3 patents with several pending. He received 7 “Best Paper” awards for his conference and journal publications which include the “Distinguished Scholar Award” from the Microbeam Analysis Society, IEEE Transactions of Advanced Packaging Commendable paper Award, IEEE Outstanding Technical Paper Award and the Philips Best Paper Award. He received his PhD from Rutgers University in 1999 in ceramic engineering, ME from the Indian Institute of Science, Bangalore and BS from the Indian Institute of Technology, Kanpur (1993).

• David Reisner, Founder, Inframat
  He is an MIT-trained Ph.D.and has extensive background in energy storage and conversion, nanotechnology, and environmental technologies.  He is a cofounder and former CEO (1996-2007) of two nanotechnology companies in Connecticut, Inframat®  and US Nanocorp®.  He was instrumental in raising over $23 million in customer-based financing (Gov’t contracts) and private equity investment.  He also managed Intellectual Property portfolios and forged strategic alliances with companies in the U.S. and China.  Both companies were recognized in Y2002 - Y2005 for their fast revenue growth as Deloitte & Touche Connecticut Technology Fast50 Award recipients. Reisner and cofounders were featured in Forbes magazine in 2004 (June 21). 
  David has over 175 publications and is an inventor on 10 issued patents.  He is the editor for the Bionanotechnology section of the recently published 3rd Ed. of The BioMedical Eng. Handbook and is editing a monograph on Bionanotechnology for Taylor & Francis Press.  He has written articles on the business of nanotechnology in Nanotechnology Law & Business as well as the Chinese publication Science & Culture Review.
  David served a 3-year term as a Technology Pioneer for the World Economic Forum and was a panelist at the 2004 Annual Meeting in Davos and at the WEF Beijing Business Summits in 2004, 2005, and 2006 and the WEF Dalian event in 2007.  David is active on the Board of the Connecticut Venture Group and is Chairman of the Board of the Connecticut Technology Council.  He was a NASA NanoTech Briefs Nano50 awardee in 2006.  For his efforts in the field of medical implantable nanocoatings, Reisner won the 1st annual BEACON award for Medical Technology in 2004. 
  David was recognized for his historic preservation efforts in 1994 when he received the Volunteer Recognition Award from the Connecticut Historical Commission and the Connecticut Trust for Historic Preservation.  David is known nationally for his expertise in Corvette restoration and documentation.  He has 3 children, his oldest attending Wesleyan Univ. and Dartmouth. David is a 1978 University Honors graduate from Wesleyan Univ. and received his Ph.D. at MIT in 1983 in the field of chemical physics.  He is a member of the Connecticut Academy of Science and Engineering.

• Scott Rickert, Co-Founder, President and Chief Executive Officer, Nanofilm
  Dr. Rickert is among the earliest pioneers in the field of nanotechnology.  His innovative research work began during his tenure as a Professor of Macromolecular Science at Case Western Reserve University in Cleveland, Ohio, in the 1980s.  By 1985, Dr. Rickert recognized the immense, untapped potential of nanotechnology and founded Nanofilm, built on the foundation of his laboratory studies. 
  The company’s first patented nano-scale film was commercialized that year with a major international optical company.  Today, Dr. Rickert heads a company with a substantial portfolio of commercialized and research technology, serving customers around the globe.  He leads a staff of 50, doing work in a 50,000-square-foot research, lab production and manufacturing space in Valley View, Ohio, near Cleveland.  He has helped Nanofilm develop nanotechnology-based research and commercial relationships with a number of global corporations, including Ferro and Carl Zeiss Vision, Inc., among others.
  Dr. Rickert’s scientific knowledge and deep experience in nanotechnology commercialization has made him a trusted advisor to a variety of industries, government entities, global organizations and policy development groups. 

• Jeff Rosedale, Co-Chair of Woodcock Washburn’s Nanotechnology and Cleantechnology Practice Groups
  Jeffrey H. Rosedale, Ph.D., J.D. is a registered patent attorney and is Co-Chair of Woodcock Washburn’s Nanotechnology and Cleantechnology Practice Groups.  His clients range from Fortune 500 corporations for materials and medical devices to entrepreneurial start-ups in the nanotech and cleantech spaces.  Major universities and federal laboratories also call on Jeff’s expertise to protect their innovations in complex technologies involving, inter alia, nanotechnology, biotechnology, electro-optical materials, display technologies, alternative energy sources and chemical process engineering. He is an active member of the U.S. Patent and Trademark Offices’ “Nanotechnology Customer Partnership” and has been the session chair and co-organizer of nanotech specific panels for the 2005 and 2006 national meetings of the Biotechnology Industry Organization (BIO) as well as the 2007 meeting of the Nano Science and Technology Institute (NSTI).  Jeff is a board member of the New Jersey Technology Council (NJTC), and serves as a Director of its Nanotechnology Networking Group.  He also serves the Nanotechnology Institute (NTI) in Philadelphia as a member of its Commercial Advisory Group.
  Prior to patent law, Jeff was a research scientist in flat panel display technologies for Rohm and Haas Company, and was a Member of the Technical Staff at AT&T Bell Laboratories, Murray Hill New Jersey.  He holds B.S.E., M.E., and Ph.D. degrees in chemical engineering from Princeton University, Stevens Institute of Technology, and the University of Minnesota, respectively, as well as a Certificate in Business Management from the University of Pennsylvania Wharton Management Program, and a J.D. from Temple Law School.  He has co-authored over 20 technical and legal publications, and is a co-inventor on four patents.

• Robert D. “Skip” Rung, President and Executive Director, Oregon Nanoscience and Microtechnologies Institute
  Mr. Rung is a senior high technology R&D executive with over 25 years of R&D management experience in CMOS process technology, application-specific integrated circuit (ASIC) design and electronic design automation (EDA), IC packaging, MEMS, microfluidics, and inkjet printing.  Shortly after retiring in 2001 as the director of Advanced Research and Development at Hewlett-Packard’s Corvallis, OR inkjet technology headquarters, Mr. Rung was asked to start up the Oregon Nanoscience and Microtechnologies Institute (ONAMI), Oregon’s first “Signature Research Center” and an unprecedented collaboration among Oregon’s research universities and the Pacific Northwest National Laboratory. ONAMI’s dual mission is to grow “small tech” research in Oregon and commercialize technology in order to extend the success of Oregon’s world-leading “Silicon Forest” technology cluster, which includes the most advanced R&D and manufacturing operations for leading companies such as Intel Corporation, Hewlett-Packard Company, FEI Company, Invitrogen/Life Technologies, Flir, Precision Castparts, Electro Scientific Industries, Planar Systems, Xerox Office Products, Tektronix,  ON Semiconductor and many dynamic smaller firms.  ONAMI has so far received $42M in state investment and approximately quadrupled Oregon’s annual federal and private research awards in the fields of nanolaminates and transparent/printed electronics, green nanotechnology, nanoscale metrology, and microtechnology-based energy and chemical systems (MECS).  The ONAMI gap fund has helped launch or enable 14 spinoff or startup companies since late 2006.

• Penelope T. Salmons, President, Rosseter NonoComposites, LLC
  Penelope Salmons leverages over twenty years of global management experience in facilitating businesses to transform by monetizing their assets, identifying their intellectual capital; differentiating their core business and devising an effective roadmap to success. Her experience spans the sectors of Nanotechnology, Capital Markets, High-Tech, Healthcare, Life Science and Energy in the spectrum of Capital Formation, Professional Services, Quality Assurance, Operational Assessment/ Benchmarking, Knowledge Management, Business Development and Alliance Management.
  She is the President of Rosseter NonoComposites, LLC, a spin off of Rosseter Holdings, Ltd, a global leader in the manufacturing of true carbon nanotubes, nanostructured carbon materials and nanocomposites. Prior to that she was a Managing Director with ITF Global Partners. She held executive leadership positions for sixteen years with IBM, InforMax (Bioinformatics) and with several start-ups. Her past hands-on experience in the public sector spans board membership of Heartbeat International, American Foundation of Greek Language and Culture, League of Women Voters and several other diverse set of social enterprises. Penelope received her Master degree from Harvard University in 07 and her Bachelor in Computer Sciences from the University of Florida in 1980.

• Paul Stimers, Associate, K&L Gates
  Paul Stimers focuses his lobbying efforts on matters related to nanotechnology, information technology policy, and defense, and advises a wide range of companies and industry associations in pursuing legislation and representing their interests before Congress and Federal agencies.
  Paul represents the NanoBusiness Alliance, the nanotechnology industry association, in developing and advocating for policies that will expand the nation’s nanotechnology infrastructure. He coordinates the Alliance’s annual Policy Tour, which brings dozens of nanotechnology leaders to the capital for meetings with senior government officials. He also works with several of the world’s leading nanotechnology companies to secure federal funding for research and development projects. In the field of information technology policy, Paul works with software companies and industry associations to ensure data and network security without restricting technological development. He also advises the Alliance for Digital Progress – a coalition of technology companies, consumer groups, and public–interest organizations – in its efforts to prevent technology mandates.
  Paul has significant knowledge of and experience in defense and homeland security issues. He represents a number of companies working with the Department of Defense in the areas of RDT&E and procurement.
  Working with Water Advocates, a non–profit organization raising awareness of the need for safe drinking water and sanitation worldwide, Paul helped to pass the Water for the Poor Act of 2005, which for the first time commits the United States to making water development a major foreign policy goal.
  Paul was senior editor of the Journal of Law and Public Policy at Harvard Law School. While attending Harvard’s Kennedy School of Government, Paul was a charter member of the Harvard Association for Law and Policy and a member of the Council for Emerging National Security Affairs. At the Kennedy School, Paul specialized in national security, focusing on terrorism, weapons of mass destruction and defense planning. Before coming to K&L Gates, Paul worked as an intern with Representative George Nethercutt (R–WA) and for the Department of the Navy.

• Todd Vare, Partner, Intellectual Property Department of Barnes & Thornburg LLP
  Todd G. Vare is a partner in the Intellectual Property Department of Barnes & Thornburg LLP, where he concentrates his practice in the litigation of patent disputes and counseling on the protection of intellectual property assets, and co-chair of the firm’s Business and Technology (BTech) Group. Mr. Vare has litigated patent disputes covering a wide variety of technologies, including gene sequencing, pharmaceuticals, medical devices, telecommunications, software programs and processes, cellular antenna systems, and mechanical devices. Mr. Vare also has litigated a variety of other intellectual property and business disputes in state and federal courts involving trade secrets, copyright, software performance, software licenses, employee non-compete and non-disclosure agreements, and rights of publicity. He is a frequent speakeron trial and litigation techniques, multi-media trial presentation strategies, and electronic discovery. In addition to trial work, Mr. Vare has significant federal and state appellate court experience. He has represented clients in appeals before the 7th Circuit, the Federal Circuit, and the 11th Circuit. He won a reversal of a summary judgment of noninfringement for his client in Dorel Juvenile Group, Inc. v. Graco Children’s Products, Inc. Mr. Vare also has argued before the United States Supreme Court in U.S. v. Santos, which resulted in a victory for his client involving the scope of the federal money laundering statute. Mr. Vare is co-chairman of the firm’s Nanotechnology Practice Group and a member of the firm’s Life Sciences and Business and Technology Group (BTech) practice groups. In these roles, Mr. Vare counsels clients on a variety of matters along the pathway of “concept to commercialization” in the life sciences and technology industries, as well as the application of nanotechnology to these and other industry sectors. His client counseling includes IP protection, computer and software protection, e-commerce processes, electronic signatures, Internet security, and other business technology matters. Mr. Vare is admitted to practice in Indiana and Illinois, the U.S. Supreme Court, the U.S. Courts of Appeals for the Federal Circuit, the 7th Circuit, the 11th Circuit, and the U.S. District Courts for the Northern District of Illinois, Southern District of Indiana, and Northern District of Indiana. Mr. Vare devotes a considerable portion of his time to pro bono matters and regularly accepts appointments under the Criminal Justice Act from the 7th Circuit Court of Appeals. Mr. Vare received his J.D. summa cum laude from Indiana University School of Law - Indianapolis in 1994. He graduated from Miami University in 1987 with a B.A. in international studies in 1987. He also received an M.B.A. from the Indiana University School of Business in 1989, and worked in marketing communications before attending law school.

• Steven R. Waite,
  Stephen Waite is currently a partner at Research 2.0, a boutique research and investment strategy firm specializing in technology and advisory services. Steve is a noted institutional investment manager, strategic corporate advisor, professor and author, with 25 years of experience on Wall Street. He was a co-founder of a multi-billion dollar investment management firm.
  Steve has extensive experience in global economic and financial market issues with tenures at Morgan Stanley & Co, The Capital Group, Merrill Lynch, and CSAM/BEA Associates. In addition, he helped found ThelnfoPro, Inc., an independent technology research firm, and served as the company’s Chief Knowledge Officer and was a member of the Board of Directors. Steve also served on the Strategic News Service Future in Review (FiRe) Technology Conference Advisory Board, NanoDynamics, Inc. Scientific Advisory Board, and has worked with the partners at GaveKal Research. He is currently on the NanoBusiness Alliance Advisory Board.
  A highly-rated Adjunct Professor of Finance at Quinnipiac University in Hamden, Connecticut, Steve is the author of the book Quantum Investing and co-author of the book, Boomernomics. He has a Masters Degree in Economics from The Pennsylvania State University and is a past participant at the Santa Fe Institute.

• David Wallace , Attorney, Chadbourne & Parke LLP
  David Wallace is a litigation partner at the New York-based international law firm of Chadbourne & Parke, where he founded and leads the firm’s multidisciplinary nanotechnologies practice. He frequently writes and speaks on a range of nanotechnology-related topics and also serves on the Advisory Board of Nanotechnology Law & Business as well as the Advisory Board of The Nanoethics Group at California Polytechnic State University.  An accomplished courtroom lawyer, Mr. Wallace’s practice is focused on all phases of complex, health-related products liability and related counseling. For two decades, he has counseled, coordinated and personally litigated the defense of multinational corporations in civil- and common-law jurisdictions globally.

• Charles (Chad) F. Wieland III, Shareholder, Buchanan, Ingersoll & Rooney PC
  Charles (Chad) F. Wieland III focuses his practice on advising clients ranging from start-ups to Fortune 100 companies, both domestic and international, on Intellectual Property (IP) matters. With over 20 years experience, he finds cost effective ways to capture and exploit the IP rights of clients, while avoiding or mitigating the hazards posed by the IP rights of others.